Latest Module Specifications
Current Academic Year 2025 - 2026
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Description To provide the students with clinical exposure and the ability to engage with clinicians successfully to solve design problems. To expose students to real world problems associated with the use of a range of current clinical scenarios. The focus is on clinical needs identification, needs synthesis, concept generation, and early concept screening that incorporates not only technical and clinical feasibility but also intellectual property assessments (patentability and freedom to operate), regulatory pathways, reimbursement considerations, and business model insights; recognising that these are essential criteria during Biodesign concept screening. The module facilitates students to develop the necessary skills to communicate effectively with medical practitioners and to solve design problems in relation to clinical needs in conjunction with clinicians. To engender in the students an awareness of the constraints within the environment of medical practitioners and the ethical implications of their work. By integrating perspectives from healthcare systems, regulatory science, reimbursement landscapes, and early value modelling, students will learn to frame problems and select concepts that are not only technically sound but also viable within real world clinical and commercial contexts. The module introduces students to ethical dilemmas facing medical innovators, including global inequalities (UN SDG 10) and issues pertaining to Good Health and Well-being (UN SDG 3). | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Learning Outcomes 1. Critically evaluate and contextualise the Stanford Biodesign Process, with particular emphasis on the Identify and Invent phases, including how regulatory pathways, reimbursement environments and business-model considerations inform early concept screening (EI-PO1, EI-PO8). 2. Analyse complex, ill-defined healthcare problems by synthesising clinical observations, stakeholder perspectives and system constraints to identify and prioritise unmet clinical needs (EI-PO2, EI-PO4). 3. Formulate clear, solution-agnostic clinical need statements that define engineering problems while accounting for professional, ethical, societal and sustainability considerations (EI-PO2, EI-PO5). 4. Generate and develop multiple concept solutions in response to identified clinical needs using structured ideation and design methodologies (EI-PO3, EI-PO4). 5. Apply and justify systematic early-stage concept screening decisions, incorporating technical feasibility, regulatory classification, reimbursement context and preliminary business considerations (EI-PO3, EI-PO8). 6. Investigate relevant prior art, standards, clinical practice and emerging technologies to support needs filtering and concept selection (EI-PO4, EI-PO1). 7. Demonstrate professional and ethical judgement in early-stage medical technology innovation, including consideration of patient safety, equity, sustainability and societal impact (EI-PO5, EI-PO8). 8. Work effectively as a member of multidisciplinary teams and reflect on individual learning needs in the context of medical technology innovation (EI-PO6). 9. Communicate clinical needs, design concepts and concept-screening rationale effectively to technical and non-technical stakeholders using appropriate written, visual and oral formats (EI-PO7, EI-PO3). | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Indicative Content and Learning Activities
Indicative Description Whilst the Stanford Biodesign Course comprises two successive modules, the focus of this module is in the early stage of the innovation process, namely needs finding through to concept creation with some additional focus on concept selection. In particular, the module will also explore how engineering technologies may be used to explore the feasibility of each concept proposed whereby technical work packages will be proposed which will enable the best concept to be identified with a view to commercialisation in the longer-term. The module is completely continuously assessed. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Indicative Reading List Books:
Articles: None | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Resources None | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||